Price to Earning ratio Analysis of Blueprint Medicines Corp - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY PE
Period Ending - Dec-23
Very Poor PE
-11.52
Period Ending - Dec-22
Very Poor PE
-10.63
Growth
-8.36 %
Trailing Twelve Months PE
Period Ending - Dec-23
Very Poor PE
-22.52
PE Analysis of Blueprint Medicines Corp
| P/E Ratio -22.52 of Blueprint Medicines Corp is negative because of negative EPS. |
| PE Ratio of BPMC has fallen by -8.36 % Compared to previous Financial Year. |
| PE Ratio with value of 18.89 was highest in Year Dec-20 in last Five Years. |
| PE Ratio of BPMC trending down for at least three Years. |
| Latest PE Ratio with value of -11.52 is lower than Average PE of -5.40 in last five years. |
Other PE Related Info of BPMC that may interest you.
Blueprint Medicines Corp Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| BPMC | 105.56 | 106.36 | 0.752 % | Biotechnology |
Defination of Price to Earning
PE Ratio measures the relationship between the company's current stock price and EPS (Earnings Per Share). PE Ratio indicates how many times investors pay money to get 1 rupee of return. It is one of the important parameters to evaluate whether a company's stock price is overvalued or undervalued. more ..
PE Related Ratios
| PriceToSalesRatio | PriceToBookRatio | PriceToCashFlowRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Price to Earning of Blueprint Medicines Corp
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| PE | -11.52 | -10.63 | -9.21 | 18.89 | -14.52 | -19.57 | -26.93 |
| Change | -8.36 % | -15.53 % | -148.73 % | 230.09 % | 25.79 % | 27.35 % | 32.72 % |
FY Chart of Price to Earning of Blueprint Medicines Corp
Note : All Data Generated at the End of Trading Hours (EOD Data)